FDA
approval
· 2024-05-01
FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application to authorize Voquezna Dual Pak, a fixed-dose combination of vonoprazan fumarate and amoxicillin, for the treatment of He…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)